beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-alpha-D-Galp

Term ID

CHEBI:148593

Synonyms

(2S,3R,4S,5R,6R)-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol
beta-D-gluco-hexopyranosyl-(1->6)-beta-D-gluco-hexopyranosyl-(1->6)-alpha-D-galacto-hexopyranose
beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-alpha-D-galactopyranose
Glc(b1-6)Glc(b1-6)a-Gal
WURCS=2.0/2,3,2/[a2112h-1a_1-5][a2122h-1b_1-5]/1-2-2/a6-b1_b6-c1

Definition

A trisaccharide consisting of two beta-D-glucopyranose residues and an alpha-D-galactopyranose residue joined in sequence by (1->6) glycosidic bonds.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-alpha-D-Galp

Phenotype where environments contain beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-alpha-D-Galp

Phenotype modified by environments containing beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-alpha-D-Galp

Human Disease Model